Growth factors in inflammatory bowel disease

Paul L. Beck, Daniel K. Podolsky

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

The pathogenesis of both ulcerative colitis and Crohn's disease is unknown but these forms of inflammatory bowel disease (IBD) may be associated with an inability of the intestinal mucosa to protect itself from luminal challenges and/ or inappropriate repair following intestinal injury. Numerous cell populations regulate these broad processes through the expression of a complex array of peptides and other agents. Growth factors can be distinguished by their actions regulating cell proliferation. These factors also mediate processes such as extracellular matrix formation, cell migration and differentiation, immune regulation, and tissue remodeling. Several families of growth factors may play an important role in IBD including: epidermal growth factor family (EGF) [transforming growth factor α (TGFα), EGF itself, and others], the transforming growth factor β (TGFβ) super family, insulin-like growth factors (IGF), fibroblast growth factors (FGF), hepatocyte growth factor (HGF), trefoil factors, platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and others. Collectively these families may determine susceptibility of IBD mucosa to injury and facilitate tissue repair.

Original languageEnglish (US)
Pages (from-to)44-60
Number of pages17
JournalInflammatory Bowel Diseases
Volume5
Issue number1
StatePublished - Feb 1999

Fingerprint

Inflammatory Bowel Diseases
Intercellular Signaling Peptides and Proteins
Transforming Growth Factors
Epidermal Growth Factor
Hepatocyte Growth Factor
Fibroblast Growth Factors
Platelet-Derived Growth Factor
Wounds and Injuries
Somatomedins
Intestinal Mucosa
Ulcerative Colitis
Crohn Disease
Vascular Endothelial Growth Factor A
Cell Movement
Extracellular Matrix
Cell Differentiation
Mucous Membrane
Cell Proliferation
Peptides
Population

Keywords

  • Crohn's disease
  • Epidermal growth factor family
  • Fibroblast growth factors
  • Hepatocyte growth factor
  • Inflammatory bowel disease
  • Insulin-like growth factors
  • Transforming growth factor α
  • Transforming growth factor β
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Growth factors in inflammatory bowel disease. / Beck, Paul L.; Podolsky, Daniel K.

In: Inflammatory Bowel Diseases, Vol. 5, No. 1, 02.1999, p. 44-60.

Research output: Contribution to journalArticle

@article{7a39ade55842440e90d6ef5d6eb3b26f,
title = "Growth factors in inflammatory bowel disease",
abstract = "The pathogenesis of both ulcerative colitis and Crohn's disease is unknown but these forms of inflammatory bowel disease (IBD) may be associated with an inability of the intestinal mucosa to protect itself from luminal challenges and/ or inappropriate repair following intestinal injury. Numerous cell populations regulate these broad processes through the expression of a complex array of peptides and other agents. Growth factors can be distinguished by their actions regulating cell proliferation. These factors also mediate processes such as extracellular matrix formation, cell migration and differentiation, immune regulation, and tissue remodeling. Several families of growth factors may play an important role in IBD including: epidermal growth factor family (EGF) [transforming growth factor α (TGFα), EGF itself, and others], the transforming growth factor β (TGFβ) super family, insulin-like growth factors (IGF), fibroblast growth factors (FGF), hepatocyte growth factor (HGF), trefoil factors, platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and others. Collectively these families may determine susceptibility of IBD mucosa to injury and facilitate tissue repair.",
keywords = "Crohn's disease, Epidermal growth factor family, Fibroblast growth factors, Hepatocyte growth factor, Inflammatory bowel disease, Insulin-like growth factors, Transforming growth factor α, Transforming growth factor β, Ulcerative colitis",
author = "Beck, {Paul L.} and Podolsky, {Daniel K.}",
year = "1999",
month = "2",
language = "English (US)",
volume = "5",
pages = "44--60",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Growth factors in inflammatory bowel disease

AU - Beck, Paul L.

AU - Podolsky, Daniel K.

PY - 1999/2

Y1 - 1999/2

N2 - The pathogenesis of both ulcerative colitis and Crohn's disease is unknown but these forms of inflammatory bowel disease (IBD) may be associated with an inability of the intestinal mucosa to protect itself from luminal challenges and/ or inappropriate repair following intestinal injury. Numerous cell populations regulate these broad processes through the expression of a complex array of peptides and other agents. Growth factors can be distinguished by their actions regulating cell proliferation. These factors also mediate processes such as extracellular matrix formation, cell migration and differentiation, immune regulation, and tissue remodeling. Several families of growth factors may play an important role in IBD including: epidermal growth factor family (EGF) [transforming growth factor α (TGFα), EGF itself, and others], the transforming growth factor β (TGFβ) super family, insulin-like growth factors (IGF), fibroblast growth factors (FGF), hepatocyte growth factor (HGF), trefoil factors, platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and others. Collectively these families may determine susceptibility of IBD mucosa to injury and facilitate tissue repair.

AB - The pathogenesis of both ulcerative colitis and Crohn's disease is unknown but these forms of inflammatory bowel disease (IBD) may be associated with an inability of the intestinal mucosa to protect itself from luminal challenges and/ or inappropriate repair following intestinal injury. Numerous cell populations regulate these broad processes through the expression of a complex array of peptides and other agents. Growth factors can be distinguished by their actions regulating cell proliferation. These factors also mediate processes such as extracellular matrix formation, cell migration and differentiation, immune regulation, and tissue remodeling. Several families of growth factors may play an important role in IBD including: epidermal growth factor family (EGF) [transforming growth factor α (TGFα), EGF itself, and others], the transforming growth factor β (TGFβ) super family, insulin-like growth factors (IGF), fibroblast growth factors (FGF), hepatocyte growth factor (HGF), trefoil factors, platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and others. Collectively these families may determine susceptibility of IBD mucosa to injury and facilitate tissue repair.

KW - Crohn's disease

KW - Epidermal growth factor family

KW - Fibroblast growth factors

KW - Hepatocyte growth factor

KW - Inflammatory bowel disease

KW - Insulin-like growth factors

KW - Transforming growth factor α

KW - Transforming growth factor β

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=0033072530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033072530&partnerID=8YFLogxK

M3 - Article

C2 - 10028449

AN - SCOPUS:0033072530

VL - 5

SP - 44

EP - 60

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 1

ER -